Human study aims to find first-ever defence to mitigate risk of zoonotic pathogen The first in-humans clinical trial of a ...

“The discovery that memory B cells and antibodies specific to [Nipah] persist 20 years post-infection suggests that vaccines ...

Innovent Biologics, a biopharmaceutical company based in Shuzou, China, has agreed a collaboration with Roche to develop ...